These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 5761066)

  • 1. Concentrate of factor VIII (FI-O-Ta) for clinical use.
    Simonetti C; Casillas G; Pavlovsky A; Bachmann A
    Thromb Diath Haemorrh Suppl; 1968; 35():245-52. PubMed ID: 5761066
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isolation and some properties of factor VIII (antihemophilic factor)].
    Bykowska K; Lopaciuk S; Michalski R
    Acta Haematol Pol; 1976 OCT-DEC; 7(4):283-92. PubMed ID: 998139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the purification and characterization of human factor 8.
    Marchesi SL; Shulman NR; Gralnick HR
    J Clin Invest; 1972 Aug; 51(8):2151-61. PubMed ID: 4626584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methods of preparing Factor VIII. I. Preparation and characteristics of a medium-pure concentrate].
    Perote P; Altamirano P; Aperador R; Camacho Y; Acosta J
    Sangre (Barc); 1984; 29(3):321-8. PubMed ID: 6435268
    [No Abstract]   [Full Text] [Related]  

  • 5. Separation of factor VIII/von Willebrand factor from fibrinogen by chromatography on Ristocetin-Sepharose.
    Vukovich TC; Karner E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):94-7. PubMed ID: 6192060
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro study of different factor VIII concentrates. Biochemical and structural characteristics of factor VIII (author's transl)].
    Massot M; Vidal A; Más J; Laguna V; Vilanova X
    Sangre (Barc); 1982; 27(1):39-52. PubMed ID: 6808678
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience with FI-O-Ta.
    Pavlovsky A; De Tezanos Pinto M
    Thromb Diath Haemorrh Suppl; 1968; 35():27-34. PubMed ID: 5761071
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII.
    Foster PR; Griffin BD; Bienek C; McIntosh RV; MacGregor IR; Somerville RA; Steele PJ; Reichl HE
    Vox Sang; 2004 Feb; 86(2):92-9. PubMed ID: 15023177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyvinylpyrrolidone (PVP): a new precipitating agent for human and bovine factor VIII and fibrinogen.
    Casillas G; Simonetti C
    Br J Haematol; 1982 Apr; 50(4):665-72. PubMed ID: 6802165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electrophoretic studies of human plasma cryoprecipitates with a high content of antihemophilic globulin A].
    Kleint V; Wegner H
    Z Gesamte Inn Med; 1970 Apr; 25(7):312-4. PubMed ID: 5521442
    [No Abstract]   [Full Text] [Related]  

  • 11. Levels of hepatitis B antigen and isoagglutinins in clinical concentrates of factor VIII and prothrombin complex.
    Wickerhauser M
    Dev Biol Stand; 1974; 27():172-7. PubMed ID: 4463121
    [No Abstract]   [Full Text] [Related]  

  • 12. Fractions rich in factor VIII.
    Blombäck M; Blombäck B
    Bibl Haematol; 1968; 29():1116-21. PubMed ID: 5700307
    [No Abstract]   [Full Text] [Related]  

  • 13. Electrophoretic procedures.
    Perret BA
    Curr Probl Clin Biochem; 1984; 14():179-224. PubMed ID: 6439478
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma fractionation in the United States. A review for clinicians.
    Ness PM; Pennington RM
    JAMA; 1974 Oct; 230(2):247-50. PubMed ID: 4137885
    [No Abstract]   [Full Text] [Related]  

  • 15. [Development of a competitive enzyme immunoassay for factor VIII-related antigen].
    Riemer J; Kopperschläger G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(1):72-83. PubMed ID: 6202602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII concentrate: what is "high purity"?
    Schoppmann A; Weber A; Hondl F; Linnau Y
    Thromb Haemost; 1994 Sep; 72(3):483-4. PubMed ID: 7855803
    [No Abstract]   [Full Text] [Related]  

  • 17. Multi-channel preparation of fresh blood an economic therapy with blood components.
    Schneider W; Glassner K; Fröhlich C; McCarty LJ
    Blut; 1974 Feb; 28(2):100-8. PubMed ID: 4130177
    [No Abstract]   [Full Text] [Related]  

  • 18. Factor VIII fractionation on aminohexyl Sepharose with possible reduction in hepatitis B antigen.
    Austen DE; Smith JK
    Thromb Haemost; 1982 Aug; 48(1):46-8. PubMed ID: 6813994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factor VIII concentrate, highly purified and heated in solution (author's transl)].
    Heimburger N; Schwinn H; Gratz P; Lüben G; Kumpe G; Herchenhan B
    Arzneimittelforschung; 1981; 31(4):619-22. PubMed ID: 6788045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Substitution of antihemophilic globulin (factor VIII) with special reference to Pool's cold fractionation].
    Matthes M; Engbring H; Winckelmann G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(4):434-40. PubMed ID: 4107580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.